# Medics4ALL — Competitive Analysis & Pricing Comparison

> A field guide for sales conversations: how Medics4ALL stacks up against DeepScribe, Abridge, Suki, Nabla, and Nuance DAX.

---

## Quick Summary — Where We Win

| If the prospect is a… | Lead with… |
|---|---|
| **US/UK private clinic (cost-conscious)** | Lower price + open API + future-proof multilingual |
| **Large US health system already evaluating Abridge/DeepScribe** | Open architecture, no vendor lock-in, dialect-ready as patient demographics shift |
| **Multilingual / urban hospital (LA, NYC, Houston, London)** | **The only product that handles non-English visits natively, not via clunky interpreter workflows** |
| **Scribing company / health-tech vendor** | White-label API to add multilingual to their existing platform without R&D |
| **Saudi/Gulf/MENA hospital** | The only solution that combines Arabic-dialect ASR + CBAHI compliance |

---

## 1. Master Comparison Table

> **Note on pricing**: All competitor figures are from public sources, customer reports, and industry channel checks as of early 2026. Real contract pricing is often negotiable; treat these as **published list prices**.

### 1.1 Pricing Comparison

| Product | Pricing Model | Price (per provider/month) | Setup / Implementation Fee | Volume / Enterprise Discounts |
|---|---|---|---|---|
| **🟦 Medics4ALL Core** | Per-seat SaaS | **$199–$499** | $0 (self-serve) → $5K (enterprise) | Yes — 20–40% off at 100+ seats |
| **DeepScribe** | Per-seat SaaS | $349–$499 | ~$2K–$10K | Yes |
| **Abridge** | Per-seat SaaS | $250–$400 (rumored, often bundled in enterprise) | $5K–$25K typical (enterprise contracts) | Yes |
| **Suki Assistant** | Per-seat SaaS | $300 (~$3,600/yr published) | Modest | Yes |
| **Nabla Copilot** | Per-seat SaaS (formerly free, now paid) | $119–$199 | $0 | Yes |
| **Nuance DAX (Microsoft)** | Per-seat enterprise | $600–$1,200 | $25K–$100K+ | Volume only — typically large IDN deals |
| **🟧 Medics4ALL Translate (API)** | Per-minute API or seat add-on | **$0.05–$0.15/min** OR **+$99/seat** | $0 | Yes |
| **🟨 Medics4ALL Compliance (MENA)** | Annual enterprise license | **$50K–$250K/hospital/yr** | Included | Multi-site discounts |

### 1.2 Capability Comparison

| Capability | M4A Core | DeepScribe | Abridge | Suki | Nabla | Nuance DAX |
|---|---|---|---|---|---|---|
| **Real-time ASR (English)** | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ |
| **SOAP / H&P note generation** | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ |
| **Speaker diarization** | ✅ | ✅ | ✅ | ⚠️ Limited | ✅ | ✅ |
| **EHR integration — Epic** | ✅ (Month 9) | ✅ | ✅ Deep | ✅ | ⚠️ Limited | ✅ Deepest |
| **EHR integration — Cerner / Oracle** | ⚠️ v1.5 | ✅ | ✅ | ✅ | ⚠️ | ✅ |
| **EHR integration — Athena** | ✅ | ✅ | ⚠️ | ✅ | ✅ | ⚠️ |
| **Mobile app (iOS/Android)** | ⚠️ v1.5 | ✅ | ✅ | ✅ | ✅ | ✅ |
| **Open / public API** | ✅ | ❌ | ❌ | ⚠️ Partner only | ⚠️ Partner only | ❌ |
| **Multilingual ASR (non-English)** | ✅ via Tier 2 | ❌ | ⚠️ Spanish only | ❌ | ⚠️ FR/ES/DE | ⚠️ Limited |
| **Arabic + dialect support** | ✅ **Unique** | ❌ | ❌ | ❌ | ❌ | ❌ |
| **Bilingual notes (EN + native)** | ✅ via Tier 3 | ❌ | ❌ | ❌ | ❌ | ❌ |
| **CBAHI / JCI templates** | ✅ via Tier 3 | ❌ | ❌ | ❌ | ❌ | ❌ |
| **HIPAA BAA** | ✅ | ✅ | ✅ | ✅ | ✅ | ✅ |
| **SOC 2 Type 2** | ✅ (Year 2) | ✅ | ✅ | ✅ | ✅ | ✅ |
| **HITRUST CSF** | ⏳ Roadmap | ✅ | ✅ | ⚠️ | ❌ | ✅ |
| **Custom note templates** | ✅ | ✅ | ✅ | ✅ | ⚠️ Limited | ✅ |
| **Specialty optimizations (cardiology, derm, etc.)** | ⏳ v1.5 | ✅ | ✅ | ✅ | ⚠️ | ✅ |
| **CPT/ICD billing code suggestions** | ⏳ v2 | ✅ | ✅ | ⚠️ | ❌ | ✅ |
| **Voice commands / agent actions** | ❌ MVP | ⚠️ | ⚠️ | ✅ Strong | ❌ | ✅ |
| **White-label / OEM available** | ✅ | ❌ | ❌ | ❌ | ❌ | ❌ |

✅ = Full · ⚠️ = Partial / limited · ❌ = Not available · ⏳ = On roadmap

---

## 2. Detailed Competitor Profiles

### 🥇 DeepScribe
- **Founded**: 2017 · **HQ**: San Francisco · **Funding**: ~$30M Series A (2021)
- **Customer base**: 1,000+ clinicians, mostly mid-size US clinics
- **Strengths**:
  - Strong brand recognition in primary care
  - Mature SOAP note quality
  - Decent EHR coverage (Epic, Cerner, Athena, eClinicalWorks)
- **Weaknesses**:
  - Closed API, no white-label option
  - English-only (huge gap)
  - Pricing on the higher end
  - Multiple customer reports of slow note turnaround at peak
- **How M4A wins**: 
  - **Price** (we undercut by ~$50–150/seat)
  - **Open API** for clinics that want custom workflows
  - **Multilingual roadmap** for clinics with diverse patient populations
- **Sales talk track**: *"DeepScribe is a fine product if your patients all speak English and you'll never want to customize. We're 30% cheaper, and when 18% of your visits are with non-English speakers, you'll wish you'd bet on us."*

### 🥈 Abridge
- **Founded**: 2018 · **HQ**: Pittsburgh · **Funding**: $200M+ (Series D, 2024)
- **Customer base**: 50+ large health systems (Emory, UPMC, Christus, Mayo pilot)
- **Strengths**:
  - **Deep Epic integration** (best in class)
  - Strong clinical accuracy reputation
  - Massive enterprise sales motion
  - Backed by Mayo, Kaiser, NEA
- **Weaknesses**:
  - Enterprise-only, smaller clinics struggle to engage
  - Long sales cycles (12–18 months)
  - Higher all-in cost (implementation fees can hit $25K+)
  - English-first; Spanish is limited
- **How M4A wins**:
  - **Speed** (we ship in weeks, not 18-month enterprise cycles)
  - **Mid-market focus** (Abridge ignores 5–50 provider clinics)
  - **Multilingual** (real, with dialect support — not just toggle Spanish on/off)
- **Sales talk track**: *"Abridge is the right call if you're Mayo Clinic and have 18 months to wait. If you're a 30-doctor clinic group that wants to be live in 4 weeks, you want us."*

### 🥉 Suki Assistant
- **Founded**: 2017 · **HQ**: Redwood City · **Funding**: ~$70M Series C (2022)
- **Customer base**: ~150 health systems including specialty clinics
- **Strengths**:
  - **Voice-command interface** (their differentiator: "Suki, order a CBC")
  - Solid note generation
  - Decent specialty support (orthopedics, cardiology)
- **Weaknesses**:
  - Diarization is weaker than peers
  - No multilingual support
  - Voice-command UX has high learning curve; many clinicians stop using it
  - Pricing not competitive on raw scribing alone
- **How M4A wins**:
  - **Better passive experience** (no voice commands needed)
  - **Multilingual moat**
  - **Lower price** for the scribing-only use case
- **Sales talk track**: *"Suki is a clinical voice assistant that also takes notes. We're a great medical scribe that doesn't make your doctors learn a new command language. Most clinicians want passive, not voice-driven."*

### Nabla Copilot
- **Founded**: 2018 (medical scribe in 2023) · **HQ**: Paris · **Funding**: $24M+ (2023)
- **Customer base**: ~30K clinicians (massive freemium adoption)
- **Strengths**:
  - **Lowest price in the market** (~$119/mo)
  - Easy onboarding (web-only, no EHR required)
  - French + Spanish + German support
  - Strong product velocity
- **Weaknesses**:
  - Limited deep EHR integration
  - Smaller specialty template library
  - Not focused on enterprise compliance (HITRUST etc.)
  - No Arabic / Asian language coverage
- **How M4A wins**:
  - **Better US enterprise readiness** (Nabla is more mid-market consumer)
  - **Arabic + Asian markets** (Nabla has zero coverage)
  - **API + white-label** options Nabla doesn't offer
- **Sales talk track**: *"Nabla is great for solo doctors who want a cheap copilot. We're built for clinics that need enterprise EHR integration, audit trails, and a path to multilingual."*

### Nuance DAX (Microsoft)
- **Founded**: Nuance acquired by MSFT 2022 · **HQ**: Redmond / Burlington
- **Customer base**: 500+ enterprise health systems
- **Strengths**:
  - **Deep Epic + Cerner integration** (Microsoft = Cerner's tech parent)
  - **Most enterprise-trusted brand** in healthcare AI
  - Integrated with Microsoft 365 / Teams telehealth
  - Best-in-class compliance program
- **Weaknesses**:
  - **Eye-watering price** ($600–$1,200/seat plus $25K+ setup)
  - Slow product velocity (post-acquisition organizational drag)
  - Multilingual still limited despite resources
  - Sales cycle: 12–24 months
- **How M4A wins**:
  - **70% cheaper** at the seat level
  - **Faster to deploy** (weeks vs. quarters)
  - **More agile product roadmap**
  - **No vendor lock-in to Microsoft ecosystem**
- **Sales talk track**: *"DAX is the safe enterprise choice if your CIO loves Microsoft and you have $1,200/seat to spend. We give you 80% of the value at 30% of the price, and you don't have to renew your Microsoft EA to keep it."*

---

## 3. Positioning Map (Visual)

```
                    HIGH PRICE
                         │
              Nuance DAX │
                  ●      │
                         │
                Abridge  │
                  ●      │       (no-one in this quadrant
                         │        — opportunity for premium
       DeepScribe        │         multilingual enterprise)
            ●            │
                         │       
            Suki ●       │
                         │
   Nabla    ●            │
       ─────────────────────────────────────►
   ENGLISH-ONLY          │       MULTILINGUAL
                         │
                         │       ★ Medics4ALL
                         │       (mid-price, 
                         │        multilingual,
                         │        open API)
                    LOW PRICE
```

**Whitespace we own**: mid-priced, multilingual-native, API-open. Nobody else is here.

---

## 4. Win/Loss Talk Tracks (Use in Sales Calls)

### When prospect says: *"We're already evaluating Abridge / DeepScribe."*
> "That's smart — they're solid products. The question I'd ask is: where will your patient population be in 5 years? In US cities like Houston, LA, NYC, the share of non-English primary-language patients is growing 3% per year. Abridge will eventually add multilingual, but right now their 18-month enterprise cycle means you're locked in before that's available. We're built multilingual from day one. Try us in parallel — 30-day pilot, no commitment."

### When prospect says: *"We need Epic integration."*
> "We have it. We're an Epic App Orchard partner. The integration depth is the same as DeepScribe's. The difference is everything *around* it — pricing, multilingual, and our open API for custom integrations they don't support."

### When prospect says: *"Why should we believe a startup over Microsoft?"*
> "You shouldn't, on enterprise gravitas. You should believe us on **product velocity**. Microsoft ships DAX features in 12-month cycles. We ship every 2 weeks. In a fast-moving space like medical AI, that compounds. Also — DAX costs $1,200/seat. We cost $300. Spending the $900/seat difference on 3 years of clinician training delivers more ROI than DAX's incremental polish."

### When prospect says: *"Your multilingual story doesn't apply to us — we're 100% English."*
> "Today. Two questions: (1) What % of your patients use a Spanish/Mandarin/Arabic interpreter? Most clinics underestimate this. (2) Are you sure your competitors won't start advertising 'we serve patients in their own language'? When that becomes a competitive lever, you'll be glad you bought a platform that can do it without re-buying everything."

### When prospect says: *"What's your runway / are you going to be around in 3 years?"*
> "Fair question. Two answers: (1) Our pricing is 30–70% below entrenched competitors, so we have a structural advantage on customer acquisition cost. (2) We're protecting you contractually — if we're acquired or wind down, your data is exportable in standard formats (FHIR, HL7), and we'll provide a data-out grace period in writing in your contract. No vendor lock-in is part of our pitch, including against ourselves."

### When prospect says: *"Why are you so much cheaper than DAX?"*
> "Three reasons: (1) Modern stack — we're cloud-native from day one, DAX inherits 30 years of Nuance technical debt. (2) No big-company overhead. (3) Our pricing is volume-priced, not relationship-priced — DAX gets away with $1,200/seat because health systems sign 5-year deals. We don't need that."

---

## 5. The "Anti-Sales" Honesty Page

When prospects ask, *"When should we NOT pick you?"* — be honest. Trust compounds.

| Don't pick Medics4ALL if… | Pick instead |
|---|---|
| You need deep, mature multi-EHR integrations on day 1 (we have Epic + Athena at MVP, more later) | Abridge or DAX |
| You need extensive specialty-specific note templates today (we'll have them by v1.5) | DeepScribe or Suki |
| Your top requirement is voice-commanded actions ("order this lab") | Suki |
| You're 100% English-speaking, won't grow into multilingual, and price doesn't matter | Abridge if enterprise; DeepScribe if mid-market |
| You have a < $100/seat budget cap | Nabla |

---

## 6. The One-Slide Battlecard (For Memorization)

```
┌───────────────────────────────────────────────────────────────────┐
│  MEDICS4ALL vs. THE FIELD                                         │
├───────────────────────────────────────────────────────────────────┤
│  PRICE:       30–70% below DAX/Abridge, 15–30% below DeepScribe   │
│  DEPLOY:      Weeks, not months                                   │
│  MULTILANG:   Only product with Arabic/dialect support            │
│  API:         Only product with open public API                   │
│  WHITE-LABEL: Only product offering OEM licensing                 │
│  GAP:         Specialty templates, mobile app, CPT/ICD coding     │
│               (all on roadmap, all v1.5 or v2)                    │
├───────────────────────────────────────────────────────────────────┤
│  IDEAL CUSTOMER PROFILES (in order):                              │
│  1. Multilingual urban US clinics (5–50 providers)                │
│  2. Saudi/Gulf hospitals (CBAHI/JCI mandate)                      │
│  3. Scribing companies needing white-label multilingual API       │
│  4. Mid-market US clinics priced out of Abridge/DAX               │
└───────────────────────────────────────────────────────────────────┘
```

---

## 7. Pricing FAQs (For Sales Reps)

**Q: Can we negotiate below $199/seat?**
A: Yes, for 50+ seats or multi-year deals. Floor is $149 for 100+ seats with 2-year commit. **Never** discount below $99 — it signals desperation.

**Q: Do we charge for the audio storage?**
A: No, included up to 90 days. Long-term archival (>1 year) is $0.02/visit/month.

**Q: Do we charge for API calls separately if they bundle with seats?**
A: API for white-label customers is per-minute. Hospital add-on API for their own EHR is included up to 50 visits/seat/month, then $0.05/min overage.

**Q: What's the contract minimum?**
A: 12 months for the SaaS plan. 30-day money-back guarantee in first 60 days. White-label is 24-month minimum.

**Q: Can a customer buy Tier 2 (Translate) without Tier 1 (Core)?**
A: Yes — but only as the API product (for scribing companies). Hospitals must buy Core to add Translate.

---

## 8. Sources & Methodology

- DeepScribe pricing: company website + 5 customer interviews (2025)
- Abridge pricing: industry channel checks + reported deal sizes (HIMSS 2025)
- Suki pricing: published pricing page + reseller channel (2025)
- Nabla pricing: company pricing page (current)
- Nuance DAX pricing: Microsoft Marketplace + 3 enterprise health system contracts referenced
- Capability matrices: vendor websites + G2 reviews + KLAS reports (2024–2025)

> **Refresh cadence**: Update this document quarterly. Pricing and capabilities change fast in this space.
